Boditech Med Inc. (KOSDAQ:206640)
South Korea
· Delayed Price · Currency is KRW 13,530
+120 (0.89%)
At close: Dec 5, 2025
Boditech Med Income Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Operating Revenue | 151,753 | 138,160 | 134,219 | 118,077 | 157,708 | 144,131 | Upgrade
|
| Revenue | 151,753 | 138,160 | 134,219 | 118,077 | 157,708 | 144,131 | Upgrade
|
| Revenue Growth (YoY) | 6.97% | 2.94% | 13.67% | -25.13% | 9.42% | 97.99% | Upgrade
|
| Cost of Revenue | 63,832 | 56,867 | 53,724 | 47,443 | 59,516 | 46,697 | Upgrade
|
| Gross Profit | 87,921 | 81,294 | 80,495 | 70,634 | 98,192 | 97,434 | Upgrade
|
| Selling, General & Admin | 38,756 | 33,337 | 30,836 | 26,370 | 24,177 | 16,909 | Upgrade
|
| Research & Development | 18,329 | 15,985 | 13,410 | 14,676 | 14,258 | 11,585 | Upgrade
|
| Amortization of Goodwill & Intangibles | 981.02 | 652.85 | 918.22 | 695.87 | 643.62 | 571.01 | Upgrade
|
| Other Operating Expenses | 1,104 | 996.87 | 972.66 | 837.56 | 800.56 | 484.26 | Upgrade
|
| Operating Expenses | 61,886 | 55,164 | 52,238 | 45,962 | 46,256 | 31,418 | Upgrade
|
| Operating Income | 26,036 | 26,129 | 28,257 | 24,671 | 51,936 | 66,016 | Upgrade
|
| Interest Expense | -334.29 | -352.5 | -350.39 | -203.92 | -196.5 | -466.69 | Upgrade
|
| Interest & Investment Income | 369.17 | 1,030 | 663.8 | 332.21 | 344.11 | 97.28 | Upgrade
|
| Earnings From Equity Investments | 1,811 | -497.3 | 251.47 | - | - | -147.21 | Upgrade
|
| Currency Exchange Gain (Loss) | 4,361 | 5,806 | 1,660 | 1,887 | 3,486 | -2,833 | Upgrade
|
| Other Non Operating Income (Expenses) | -35.2 | -229.66 | 711.81 | 568.61 | 1,106 | -541.45 | Upgrade
|
| EBT Excluding Unusual Items | 32,207 | 31,886 | 31,194 | 27,255 | 56,676 | 62,125 | Upgrade
|
| Gain (Loss) on Sale of Investments | 389.32 | 563.78 | 415.34 | -330.2 | -470.48 | 182.37 | Upgrade
|
| Gain (Loss) on Sale of Assets | -259.9 | -48.52 | -48.18 | 43.62 | -86.54 | 147.31 | Upgrade
|
| Asset Writedown | - | - | - | -35.86 | -79.44 | -2,327 | Upgrade
|
| Other Unusual Items | - | - | 6.01 | 32.8 | - | 46.61 | Upgrade
|
| Pretax Income | 32,336 | 32,401 | 31,567 | 26,965 | 56,039 | 60,174 | Upgrade
|
| Income Tax Expense | 4,984 | 5,181 | 4,899 | 1,684 | 8,644 | 11,862 | Upgrade
|
| Earnings From Continuing Operations | 27,353 | 27,220 | 26,668 | 25,281 | 47,395 | 48,312 | Upgrade
|
| Minority Interest in Earnings | -126.51 | 40.33 | -721.75 | -1,130 | -3,028 | -2,823 | Upgrade
|
| Net Income | 27,226 | 27,260 | 25,947 | 24,152 | 44,367 | 45,489 | Upgrade
|
| Net Income to Common | 27,226 | 27,260 | 25,947 | 24,152 | 44,367 | 45,489 | Upgrade
|
| Net Income Growth | -0.27% | 5.06% | 7.43% | -45.56% | -2.47% | 290.47% | Upgrade
|
| Shares Outstanding (Basic) | 22 | 22 | 22 | 22 | 23 | 23 | Upgrade
|
| Shares Outstanding (Diluted) | 22 | 22 | 22 | 22 | 23 | 23 | Upgrade
|
| Shares Change (YoY) | -0.94% | -0.13% | -1.77% | -2.41% | -0.47% | 0.14% | Upgrade
|
| EPS (Basic) | 1250.56 | 1242.48 | 1181.10 | 1079.94 | 1937.17 | 1978.15 | Upgrade
|
| EPS (Diluted) | 1250.08 | 1242.00 | 1181.00 | 1079.94 | 1936.26 | 1975.90 | Upgrade
|
| EPS Growth | 0.65% | 5.17% | 9.36% | -44.23% | -2.01% | 289.98% | Upgrade
|
| Free Cash Flow | -11,556 | 13,452 | 29,695 | 7,808 | 31,697 | 40,565 | Upgrade
|
| Free Cash Flow Per Share | -530.80 | 613.11 | 1351.72 | 349.13 | 1383.14 | 1761.80 | Upgrade
|
| Dividend Per Share | 150.000 | 150.000 | 200.000 | 150.000 | 200.000 | 200.000 | Upgrade
|
| Dividend Growth | -25.00% | -25.00% | 33.33% | -25.00% | - | 300.00% | Upgrade
|
| Gross Margin | 57.94% | 58.84% | 59.97% | 59.82% | 62.26% | 67.60% | Upgrade
|
| Operating Margin | 17.16% | 18.91% | 21.05% | 20.89% | 32.93% | 45.80% | Upgrade
|
| Profit Margin | 17.94% | 19.73% | 19.33% | 20.45% | 28.13% | 31.56% | Upgrade
|
| Free Cash Flow Margin | -7.61% | 9.74% | 22.12% | 6.61% | 20.10% | 28.14% | Upgrade
|
| EBITDA | 35,706 | 34,571 | 36,489 | 32,144 | 57,977 | 71,406 | Upgrade
|
| EBITDA Margin | 23.53% | 25.02% | 27.19% | 27.22% | 36.76% | 49.54% | Upgrade
|
| D&A For EBITDA | 9,670 | 8,442 | 8,232 | 7,473 | 6,041 | 5,389 | Upgrade
|
| EBIT | 26,036 | 26,129 | 28,257 | 24,671 | 51,936 | 66,016 | Upgrade
|
| EBIT Margin | 17.16% | 18.91% | 21.05% | 20.89% | 32.93% | 45.80% | Upgrade
|
| Effective Tax Rate | 15.41% | 15.99% | 15.52% | 6.24% | 15.43% | 19.71% | Upgrade
|
| Advertising Expenses | - | 1,768 | 1,149 | 962.7 | 686.79 | 318.55 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.